Luai Ibrahim Alharbi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luai Ibrahim Alharbi has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah Donia
Department of Scientific Computing, Faculty of Computer and Artificial Intelligence, Benha University, Benha 13518, Egypt
1 shared publication - Elsayed Badr
Department of Scientific computing, Faculty of Computers and Artificial Intelligence, Benha University, Benha 19111, Egypt
1 shared publication - Eman Mounir Ali
Department of Scientific Computing, Faculty of Computer and Artificial Intelligence, Benha University, Benha 13518, Egypt
1 shared publication
Latest Publications
- Open Access
- 24 November 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (12) , 976
Comparative Multi-Omics Analysis Identifies Shared Transcriptomic Signatures and Therapeutic Targets in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) are major neurodegenerative disorders that share certain pathological features but differ in their genetic etiology and clinical presentation. Their potential molecular intersections remain incompletely understood. In this research, we conducted a comparative transcriptomic analysis using postmortem brain RNA-seq datasets from AD (GSE53697), PD (GSE68719), and HD (GSE64810) to identify shared and disease-specific transcriptional signatures. Differentially expressed genes (DEGs) were determined and functionally characterized through Gene Ontology (GO) enrichment. Protein–protein interaction (PPI) networks were generated using STRING and visualized in Cytoscape to identify central hub genes, followed by gene–disease and drug-interaction analyses to assess functional and therapeutic relevance. Ten DEGs were found to overlap among the three disorders, exhibiting variable directions of regulation across diseases. Enrichment analysis indicated convergence on immune- and inflammation-related biological processes. Key hub genes, including MMP9, LCN2, CXCL2, CCL2, S100A8, and S100A9, were identified as central nodes within the PPI network. Although the overlap in DEGs was limited, the findings suggest that neuroinflammatory signaling represents a shared molecular theme across AD, PD, and HD, warranting further validation in independent cohorts.
- 24 November 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (12) , 976
Open AccessComparative Multi-Omics Analysis Identifies Shared Transcriptomic Signatures and Therapeutic Targets in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) are major neurodegenerative disorders that share certain pathological features but differ in their genetic etiology and clinical presentation. Their potential molecular intersections remain incompletely understood. In this research, we conducted a comparative transcriptomic analysis using postmortem brain RNA-seq datasets from AD (GSE53697), PD (GSE68719), and HD (GSE64810) to identify shared and disease-specific transcriptional signatures. Differentially expressed genes (DEGs) were determined and functionally characterized through Gene Ontology (GO) enrichment. Protein–protein interaction (PPI) networks were generated using STRING and visualized in Cytoscape to identify central hub genes, followed by gene–disease and drug-interaction analyses to assess functional and therapeutic relevance. Ten DEGs were found to overlap among the three disorders, exhibiting variable directions of regulation across diseases. Enrichment analysis indicated convergence on immune- and inflammation-related biological processes. Key hub genes, including MMP9, LCN2, CXCL2, CCL2, S100A8, and S100A9, were identified as central nodes within the PPI network. Although the overlap in DEGs was limited, the findings suggest that neuroinflammatory signaling represents a shared molecular theme across AD, PD, and HD, warranting further validation in independent cohorts.